Cargando…

Structural basis of neuropeptide Y signaling through Y1 receptor

Neuropeptide Y (NPY) is highly abundant in the brain and involved in various physiological processes related to food intake and anxiety, as well as human diseases such as obesity and cancer. However, the molecular details of the interactions between NPY and its receptors are poorly understood. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Chaehee, Kim, Jinuk, Ko, Seung-Bum, Choi, Yeol Kyo, Jeong, Hyeongseop, Woo, Hyeonuk, Kang, Hyunook, Bang, Injin, Kim, Sang Ah, Yoon, Tae-Young, Seok, Chaok, Im, Wonpil, Choi, Hee-Jung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844075/ https://www.ncbi.nlm.nih.gov/pubmed/35165283 http://dx.doi.org/10.1038/s41467-022-28510-6

Ejemplares similares

Author Correction: Structural basis of neuropeptide Y signaling through Y1 receptor
por: Park, Chaehee, et al.
Publicado: (2022)

Dynamic Interactions of Fully Glycosylated SARS-CoV-2 Spike Protein with Various Antibodies
por: Cao, Yiwei, et al.
Publicado: (2021)

Structure, Dynamics, Receptor Binding, and Antibody Binding of the Fully Glycosylated Full-Length SARS-CoV-2 Spike Protein in a Viral Membrane
por: Choi, Yeol Kyo, et al.
Publicado: (2021)

Developing a Fully Glycosylated Full-Length SARS-CoV-2 Spike Protein Model in a Viral Membrane
por: Woo, Hyeonuk, et al.
Publicado: (2020)

Developing a Fully-glycosylated Full-length SARS-CoV-2 Spike Protein Model in a Viral Membrane
por: Woo, Hyeonuk, et al.
Publicado: (2020)

Structure of the Intermediate Filament-Binding Region of Desmoplakin
por: Kang, Hyunook, et al.
Publicado: (2016)

CHARMM-GUI Membrane Builder for Lipid Nanoparticles with Ionizable Cationic Lipids and PEGylated Lipids
por: Park, Soohyung, et al.
Publicado: (2021)

Sclerostin inhibits Wnt signaling through tandem interaction with two LRP6 ectodomains
por: Kim, Jinuk, et al.
Publicado: (2020)

Author Correction: Sclerostin inhibits Wnt signaling through tandem interaction with two LRP6 ectodomains
por: Kim, Jinuk, et al.
Publicado: (2022)

CHARMM-GUI Membrane Builder: Past, Current, and Future Developments and Applications
por: Feng, Shasha, et al.
Publicado: (2023)

Structural basis for ligand recognition of the neuropeptide Y Y(2) receptor
por: Tang, Tingting, et al.
Publicado: (2021)

CHARMM-GUI Multicomponent Assembler for Modeling and Simulation of Complex Multicomponent Systems
por: Kern, Nathan R., et al.
Publicado: (2023)

Structural basis of ligand binding modes at the neuropeptide Y Y(1) receptor
por: Yang, Zhenlin, et al.
Publicado: (2018)

Correlation of leptin, neuropeptide Y and amylin in childhood obesity
por: Kim, Eun Young, et al.
Publicado: (2013)

Neuropeptide Y protocols /
Publicado: (2000)

Evaluating GPCR modeling and docking strategies in the era of deep learning-based protein structure prediction
por: Lee, Sumin, et al.
Publicado: (2022)

Molecular architecture of the Gα(i)-bound TRPC5 ion channel
por: Won, Jongdae, et al.
Publicado: (2023)

Neuropeptides at the crossroad of fear and hunger: a special focus on neuropeptide Y
por: Comeras, Lucas B., et al.
Publicado: (2019)

Functional role of the Frizzled linker domain in the Wnt signaling pathway
por: Ko, Seung-Bum, et al.
Publicado: (2022)

The Role of Neuropeptide Y in the Nucleus Accumbens
por: Tanaka, Masaki, et al.
Publicado: (2021)

Elevated Pentraxin 3 in Obese Adipose Tissue Promotes Adipogenic Differentiation by Activating Neuropeptide Y Signaling
por: Shin, Min-Kyung, et al.
Publicado: (2018)

Elevated Neuropeptide Y in Endothelial Dysfunction Promotes Macrophage Infiltration and Smooth Muscle Foam Cell Formation
por: Choi, Bongkun, et al.
Publicado: (2019)

Neuropeptide Y: Biomarker and intervention for surgical recovery
por: Zhao, Dong Fang, et al.
Publicado: (2015)

The fat regulator neuropeptide Y and caloric restriction
por: Park, Seongjoon, et al.
Publicado: (2017)

The Role of Neuropeptide Y in Cardiovascular Health and Disease
por: Tan, Cheryl M. J., et al.
Publicado: (2018)

Roles of Neuropeptide Y in Neurodegenerative and Neuroimmune Diseases
por: Li, Chunrong, et al.
Publicado: (2019)

Neuropeptide Y in Alcohol Addiction and Affective Disorders
por: Thorsell, Annika, et al.
Publicado: (2017)

Neuropeptide Y Is an Immunomodulatory Factor: Direct and Indirect
por: Chen, Wei-can, et al.
Publicado: (2020)

Different Regulation of Atrial ANP Release through Neuropeptide Y(2) and Y(4) Receptors
por: Piao, Feng Lian, et al.
Publicado: (2008)

ProSAAS-Derived Peptides are Colocalized with Neuropeptide Y and Function as Neuropeptides in the Regulation of Food Intake
por: Wardman, Jonathan H., et al.
Publicado: (2011)

Relation of neuropeptide Y gene expression and genotyping with hypertension in chronic kidney disease
por: Badr, Eman A.E., et al.
Publicado: (2019)

Lin28 regulates the expression of neuropeptide Y receptors and oocyte-specific homeobox genes in mouse embryonic stem cells
por: Park, Geon Tae, et al.
Publicado: (2012)

Therapeutic potential of neuropeptide Y (NPY) receptor ligands
por: Brothers, Shaun P, et al.
Publicado: (2010)

Neuropeptide Y receptors: how to get subtype selectivity
por: Pedragosa-Badia, Xavier, et al.
Publicado: (2013)

Neuropeptide Y in the Adult and Fetal Human Pineal Gland
por: Møller, Morten, et al.
Publicado: (2014)

Response to neuropeptide Y: Biomarker and intervention for surgical recovery
por: Enman, Nicole, et al.
Publicado: (2015)

Plasma Neuropeptide Y Levels in Vasovagal Syncope in Children
por: Liao, Ying, et al.
Publicado: (2017)

Divergent effects of peripheral and global neuropeptide Y deletion
por: Wee, Natalie K.Y., et al.
Publicado: (2020)

Avian Neuropeptide Y: Beyond Feed Intake Regulation
por: Greene, Elizabeth S., et al.
Publicado: (2022)

Neuroprotective Effects of Neuropeptide Y against Neurodegenerative  Disease
por: Pain, Stéphanie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_al39c1mbrdbfe5ogl30rpc1dqe